HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT07697339 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07697339
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-10
- Primary completion
- 2027-08-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.